Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Oxygenta Pharmaceutical had annual revenue of 1.13B INR with 3.63% growth. Oxygenta Pharmaceutical had revenue of 497.87M in the quarter ending March 31, 2026, with 0.65% growth.

• Revenue: 1.13B
• Revenue Growth: +3.63%
• P/S Ratio: 1.72
• Revenue / Employee: 6.47M
• Employees: 175
• Market Cap: 1.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.13B	39.69M	3.63%
Mar 31, 2025	1.09B	696.57M	175.71%
Mar 31, 2024	396.42M	86.55M	27.93%
Mar 31, 2023	309.87M	-295.37M	-48.80%
Mar 31, 2022	605.25M	84.98M	16.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error